Abstract

Genetic modification of whole-cell cancer vaccines to augment their efficacies has a history of over two and a half decades. Various genes and gene combinations, targeting different aspects of immune responses have been tested in pursuit of potent adjuvant effects. Here we show that co-expression of two cytokine members of the common cytokine receptor γ-chain family, IL-21 and IL-7, in whole-cell cancer vaccines boosts antitumor immunity in a CD4+ and CD8+ T cell-dependent fashion. It also generates effective immune memory. The vaccine-elicited short-term effects positively correlated with enhanced infiltration of CD4+ and CD8+ effector T cells, and the long-term effects positively correlated with enhanced infiltration of effector memory T cells, especially CD8+ effector memory T cells. Preliminary data suggested that the vaccine exhibited good safety profile in murine models. Taken together, the combination of IL-21 and IL-7 possesses potent adjuvant efficacy in whole-cell vaccines. This finding warrants future development of IL-21 and IL-7 co-expressing whole-cell cancer vaccines and their relevant combinatorial regimens.

Highlights

  • Vaccination with irradiated tumor cells that are genetically modified to express genes targeting different aspects of immune responses to promote antitumor immunity has been a focus in the field of tumor immunotherapeutics for decades[1,2,3]

  • We have shown that vaccination with tumor cells co-expressing IL-21 and IL-7 elicited potent antitumor responses in both prophylactic and therapeutic tumor models

  • CD4+ and CD8+ effector T cells, and the long-term effects positively correlated with enhanced infiltration of effector memory T cells, especially CD8+ Tems

Read more

Summary

Introduction

Vaccination with irradiated tumor cells that are genetically modified to express genes targeting different aspects of immune responses to promote antitumor immunity has been a focus in the field of tumor immunotherapeutics for decades[1,2,3]. Various signals stimulate T cell to boost the potency of adaptive immune responses, a subset of which is conducted by common cytokine receptor γ-chain family cytokines, comprising IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21. Their receptors, sharing a common γsubunit, transduce signals through the Jak-STAT pathway among others, on binding to their respective ligands. IL-21 receptor, expressed on naïve, effector and memory T cells, albeit at varied levels, signals mainly through STAT3, which is a distinctive bias from other members of this receptor family. While IL-7 receptor, expressed on naïve and memory T cells, almost absent on effector T cells though, signals mainly through STAT54,5. The vaccine formulation were examined for safety concerns in murine models

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.